Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ALDOA pseudogene 2 (ALDOAP2) is a genomic locus homologous to the functional ALDOA gene, which encodes for a glycolytic enzyme involved in energy metabolism. ALDOAP2, as a pseudogene, lacks the ability to code for a functional protein product and does not have a known physiological or pathological role. It is not considered a drug target and does not participate in cellular pathways or disease processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ALDOA pseudogene 2 (ALDOAP2).